tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
MGNX Earnings this Week: How Will it Perform?
PremiumPre-EarningsMGNX Earnings this Week: How Will it Perform?
12d ago
MacroGenics Advances in Cancer Treatment with MGC028 Clinical Trial
Premium
Company Announcements
MacroGenics Advances in Cancer Treatment with MGC028 Clinical Trial
25d ago
MacroGenics’ Lorigerlimab Study: A Potential Game-Changer in Cancer Treatment?
Premium
Company Announcements
MacroGenics’ Lorigerlimab Study: A Potential Game-Changer in Cancer Treatment?
25d ago
MacroGenics’ Strategic Shift and Lorigerlimab’s Trial Impact: A Hold Rating Amid CEO Transition and Drug Development Uncertainty
PremiumRatingsMacroGenics’ Strategic Shift and Lorigerlimab’s Trial Impact: A Hold Rating Amid CEO Transition and Drug Development Uncertainty
3M ago
MacroGenics price target lowered to $5 from $8 at Leerink
Premium
The Fly
MacroGenics price target lowered to $5 from $8 at Leerink
3M ago
MacroGenics Inc. Reports Q2 2025 Financial Results
Premium
Company Announcements
MacroGenics Inc. Reports Q2 2025 Financial Results
3M ago
MacroGenics CEO Scott Koenig steps down, Eric Risser succeeds
PremiumThe FlyMacroGenics CEO Scott Koenig steps down, Eric Risser succeeds
3M ago
MGNX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
MGNX Earnings this Week: How Will it Perform?
3M ago
MacroGenics’ Prostate Cancer Study: A Potential Game-Changer?
Premium
Company Announcements
MacroGenics’ Prostate Cancer Study: A Potential Game-Changer?
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100